Analysts expect Inhibrx Biosciences, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 100,000.00 | 0.00 | 1.30 M | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.24 M | 5.54 M | 6.03 M | 6.35 M | 24.67 M | 31.09 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.11 M | 5.00 M | 4.98 M | 5.24 M | 22.94 M | 26.52 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.17 M | 5.27 M | 5.50 M | 5.80 M | 23.81 M | 28.81 M |
Analysts expect Inhibrx Biosciences, Inc. to report earnings per share of -2.56 for Q3 26, against a range of -2.65 to -2.47. The most recent reported quarter, Q2 26, came in at -2.34, a 3.7% beat against the -2.43 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.84 | -3.09 | -2.80 | -1.85 | -2.28 | -2.11 | -2.15 | -2.34 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -3.35 | -2.85 | -2.60 | -2.84 | -1.66 | -1.84 | -1.55 | -2.22 | -2.47 | -2.55 | -2.25 | -2.01 | -2.15 | -2.31 | -1.44 | -1.24 | ||||||||||
| Low Estimate | -3.87 | -3.15 | -2.94 | -3.06 | -1.98 | -2.16 | -1.73 | -2.64 | -2.65 | -3.09 | -2.59 | -2.37 | -2.43 | -2.57 | -1.62 | -1.34 | ||||||||||
| Consensus Estimate | -3.61 | -3.00 | -2.77 | -2.95 | -1.82 | -2.00 | -1.64 | -2.43 | -2.56 | -2.82 | -2.42 | -2.19 | -2.29 | -2.44 | -1.53 | -1.29 |
Pull Wall Street consensus for Inhibrx Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=INBX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "INBX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=INBX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();